Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
GlaxoSmithKline reportedly pulled its bid to purchase Pfizer's consumer healthcare business March 23, according to Reuters.
President Donald Trump's administration implemented a payment policy change that could increase the price of biosimilars, according to The Wall Street Journal.
Here are the four latest drugs or medical devices approved by the FDA since March 9.
Americans identified pharmaceutical companies as one of the most influential parties in Washington, D.C., in a poll conducted by Kaiser Family Foundation.
In the wake of the IV fluid bag shortage sparked by Hurricane Maria, which slammed Puerto Rico in September, Boston-based Brigham and Women's Hospital is using oral hydration protocol to curb IV fluid bag use, according to an article published…
The U.S. Patent and Trademark Office granted Amazon a new patent last week for a delivery drone that can react to human gestures, including screaming, flailing and a thumbs-up, reports the Los Angeles Times.
The FDA rolled out a smartphone app March 22 to provide information about prescription and over-the-counter drugs.
The FDA on March 20 approved Seattle Genetics' drug Adcetris to treat advanced forms of Hodgkin lymphoma in combination with chemotherapy.
Genentech earned FDA approval for a new method of administering its 0.3 milligram eye drug Lucentis March 21.
California issued a cease-and-desist order to Pharmedium Services, a compounding business owned by wholesaler AmerisourceBergen, according to STAT.